March 5, 2021

Yescarta Receives Follicular Lymphoma Indication

Read More
March 5, 2021

Flucelvax Quadrivalent Receives Expanded Flu Indication

Read More
March 4, 2021

Actemra Receives New Indication to Treat Interstitial Lung Disease in Patients Diagnosed with Systemic Sclerosis

Read More
March 3, 2021

Lorbrena Gains Full FDA Approval, Expanded Lung Cancer Indication

Read More
March 3, 2021

Azstarys Approved to Treat ADHD

Read More
March 1, 2021

Small Cell Lung Cancer Indications Withdrawn for Keytruda, Opdivo

Read More
March 1, 2021

Brand Medications with Generic Alternatives Anticipated to be Approved in April

Read More
February 28, 2021

Nulibry Approved to Treat Rare Genetic Disorder

Read More
February 27, 2021

Emergency Use Authorization Granted for Johnson & Johnson’s COVID-19 Vaccine

Read More
February 26, 2021

Pepaxto Approved to Treat Multiple Myeloma

Read More
February 25, 2021

Updates to Storage Requirements for Pfizer COVID-19 Vaccine

Read More
February 25, 2021

Amondys 45 Approved to Treat Duchenne Muscular Dystrophy

Read More